Synthesis and biologic activity of conformationally constrained analogs of L-363,301.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Peptide Research

• Publication date

  2008-12-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1399-3011.2005.00309.XPMID 16316457
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclic hexapeptides related to somatostatin. Conformational analysis employing 1H-NMR and molecular dynamics.

  2009cited by this paper
• Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan.

  2005cited by this paper
• Somatostatin Receptor 1 Selective Analogues: 2. Nα-Methylated Scan†

  2005cited by this paper
• Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.

  2005cited by this paper
• The Role of Subtype-specific Ligand Binding and the C-tail Domain in Dimer Formation of Human Somatostatin Receptors*

  2004cited by this paper
• A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.

  2003cited by this paper
• Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.

  2003cited by this paper
• Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.

  2003cited by this paper
• Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.

  2003cited by this paper
• Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.

  2003cited by this paper
• Drug design at peptide receptors: somatostatin receptor ligands.

  2002cited by this paper
• Drug design at peptide receptors

  2002cited by this paper
• SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.

  2002cited by this paper
• Somatostatin analogs.

  2001cited by this paper
• Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1).

  2001cited by this paper
• Synthesis of (2S,3S)-β-methyltryptophan

  2001cited by this paper
• SST3-selective potent peptidic somatostatin receptor antagonists.

  2000cited by this paper
• Optimization of a somatostatin mimetic via constrained amino acid and backbone incorporation.

  2000cited by this paper
• Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.

  2000cited by this paper
• Synthesis and binding potencies of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues

  1999cited by this paper
• Receptor-mediated Internalization Is Critical for the Inhibition of the Expression of Growth Hormone by Somatostatin in the Pituitary Cell Line AtT-20*

  1999cited by this paper
• A combinatorial approach toward the discovery of non-peptide, subtype-selective somatostatin receptor ligands.

  1999cited by this paper
• Agonist-dependent Up-regulation of Human Somatostatin Receptor Type 1 Requires Molecular Signals in the Cytoplasmic C-tail*

  1999cited by this paper
• Conformation-activity relationships of opioid peptides with selective activities at opioid receptors.

  1999cited by this paper
• Somatostatin and its receptor family.

  1999cited by this paper
• Identification of a Potent Heterocyclic Ligand To Somatostatin Receptor Subtype 5 by the Synthesis and Screening of β-Turn Mimetic Libraries

  1999cited by this paper
• Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2.

  1998cited by this paper
• A selective analog for the somatostatin sst1-receptor subtype expressed by human tumors.

  1998cited by this paper
• Spiro[1H-indene-1,4'-piperidine] derivatives as potent and selective non-peptide human somatostatin receptor subtype 2 (sst2) agonists.

  1998cited by this paper
• Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.

  1998cited by this paper
• A refined model for the somatostatin pharmacophore: conformational analysis of lanthionine-sandostatin analogs.

  1997cited by this paper
• Classification and nomenclature of somatostatin receptors.

  1995cited by this paper
• Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities.

  1995cited by this paper
• Asymmetric synthesis of unusual amino acids: Synthesis of optically pure isomers of N-indole- (2-mesitylenesulfonyl)-β-methyltryptophan

  1994cited by this paper
• Characterization of cloned human somatostatin receptor SSTR5.

  1994cited by this paper
• De novo design and synthesis of somatostatin non-peptide peptidomimetics utilizing beta-D-glucose as a novel scaffolding

  1993cited by this paper
• Molecular cloning and functional expression of a brain-specific somatostatin receptor.

  1992cited by this paper
• Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase.

  1992cited by this paper
• Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.

  1992cited by this paper
• Design and discovery in the development of peptide analogs

  1992cited by this paper
• Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase.

  1992cited by this paper
• Main chain and side chain chiral methylated somatostatin analogs : syntheses and conformational analyses

  1992cited by this paper
• Nonpeptidal peptidomimetics with a β-D-glucose scaffolding. A partial somatostatin agonist bearing a close structural relationship to a potent, selective substance P antagonist

  1992cited by this paper
• Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28.

  1992cited by this paper
• The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

  1991cited by this paper
• Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.

  1991cited by this paper
• The asymmetric synthesis of .alpha.-amino acids. Electrophilic azidation of chiral imide enolates, a practical approach to the synthesis of (R)- and (S)-.alpha.-azido carboxylic acids

  1990cited by this paper
• An improved method for anchoring of 9-fluorenylmethoxycarbonyl-amino acids to 4-alkoxybenzyl alcohol resins.

  1987cited by this paper
• N‐terminally extended somatostatin: The primary structure of somatostatin‐28

  1980cited by this paper
• Practical synthesis of cyclic peptides, with an example of dependence of cyclization yield upon linear sequence

  1979cited by this paper
• Reaction of arylsulfonyl azides with N-methylindole

  1973cited by this paper
• Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

  1973cited by this paper
• Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

  1970cited by this paper
• Some Decomposition Reactions of Acid Azides

  1963cited by this paper
• The Synthesis of the 2-Amino-3-(3-indolyl)-butyric Acids (β-Methyltryptophans)

  1957cited by this paper

• Peptidomimetics I

  2017cites this paper
• Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design.

  2016cites this paper
• Azepinone-Constrained Amino Acids in Peptide and Peptidomimetic Design

  2015cites this paper
• Conjugate Addition II

  2014cites this paper
• Aspects of Peptidomimetics

  2009cites this paper
• Electrophilic Amination of Carbanions, Enolates, and Their Surrogates

  2009cites this paper